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Abstract
Introduction: Pulmonary edema (PED) is a severe complication after aneurysmal subarachnoid hemorrhage (SAH).
PED is often treated with diuretics and a reduction in fluid intake, but this may cause intravascular volume
depletion, which is associated with secondary ischemia after SAH. We prospectively studied intravascular volume in
SAH patients with and without PED.
Methods: Circulating blood volume (CBV) was determined daily during the first 10 days after SAH by means of
pulse dye densitometry. CBV of 60-80 ml/kg was considered normal. PED was diagnosed from clinical signs and
characteristic bilateral pulmonary infiltrates on the chest radiograph. We compared CBV, cardiac index, and fluid
balance between patients with and without PED with weighted linear regression, taking into account only
measurements from the first day after SAH through to the day on which PED was diagnosed. Differences were
adjusted for age, bodyweight, and clinical condition.
Results: In total, 102 patients were included, 17 of whom developed PED after a mean of 4 days after SAH.
Patients developing PED had lower mean CBV (56.6 ml/kg) than did those without PED (66.8 ml/kg). The mean
difference in CBV was -11.3 ml/kg (95% CI, -16.5 to -6.1); adjusted mean difference, -8.0 ml/kg (95% CI, -14.0 to -2.0).
After adjusting, no differences were found in cardiac index or fluid balance between patients with and
without PED.
Conclusions: SAH patients developing pulmonary edema have a lower blood volume than do those without
PED and are hypovolemic. Measures taken to counteract pulmonary edema must be balanced against the
risk of worsening hypovolemia.
Trial registration: NTR1255.
Introduction
Pulmonary edema (PED) is a severe complication in
patients with a subarachnoid hemorrhage (SAH) from
rupture of an intracranial aneurysm [1,2]. PED can
result in severe hypoxemia and thus contribute to cere-
bral hypoxia in a brain that is already vulnerable to sec-
ondary injury. PED thereby increases the risk of poor
outcome [2,3]. Next to such well-known causes of PED
as cardiac failure or inflammatory reactions in the pul-
monary tissue (for example, in sepsis), PED after SAH
can have a neurogenic origin. Neurogenic PED is
defined as an increase in interstitial and alveolar lung
fluid occurring as a direct consequence of an acute cen-
tral nervous system injury.
In the pathophysiology of neurogenic PED, several
mechanisms are involved [1,4]. An abrupt increase in
intracranial pressure or a localized ischemic insult in so-
called neurogenic PED trigger zones, in the hypothala-
mus and medulla oblongata, leads to a massive sympa-
thetic discharge. Severe systemic and pulmonary
vasoconstriction ensues, with systemic hypertension and
a marked increase in pulmonary hydrostatic pressure.
This is followed by a fluid shift from the pulmonary
capillaries into the lung tissue. Furthermore, the cerebral
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an increase in the production of brain cytokines, which
can trigger inflammatory processes outside the brain. A
systemic inflammatory response is accompanied by
capillary leakage and the formation of generalized and
pulmonary edema. The supraphysiologic sympathetic
stimulation may also provoke cardiac dysfunctions with
rhythm and conduction disturbances and mechanical
pump failure, which contribute to the formation of PED.
Management of PED after SAH is centered on the tra-
ditional treatment strategies for cardiac failure-induced
pulmonary edema, such as a reduction in preload and
afterload and the use of inotropics [1,4,5]. A reduction
in preload, by administration of diuretics and by a
reduction in fluid intake, carries a risk of intravascular
volume depletion. Patients after SAH already have a
high risk of hypovolemia, and hypovolemia is associated
with delayed cerebral ischemia and with poor outcome
[ 6 , 7 ] .T h ea v o i d a n c eo fh y p o v o l e m i ab ya m p l ef l u i d
intake and, in some cases, the induction of hypervole-
mia, is therefore a mainstay of treatment after SAH [8].
To guide fluid management adequately, an accurate
knowledge of volume status is required.
We assessed intravascular volume in patients after
SAH and compared it between patients in whom PED
did or did not develop.
Materials and methods
Study design and setting
We performed a prospective observational study in the
UMC Utrecht, as a substudy of the Optica study. In that
prospective controlled study, fluid management guided
by daily measurements of circulating blood volume was
compared with a fluid policy based on regular evalua-
tions of the fluid balance, to assess its effect on the inci-
dence of hypovolemia [9].
The study period was days 1 through 10 after the
onset of SAH. The Medical Ethics Review Committee of
the UMC Utrecht approved the study, and written
informed consent was obtained.
Study population
Patients were eligible if admitted to the UMC Utrecht
within 72 h after aneurysmal SAH. Patients with accom-
panying head injury, pregnancy, liver or kidney failure,
an allergy for the indicator dye indocyanine green, or
with imminent death on admission were excluded.
Patient data on demographic and clinical variables were
collected prospectively. The clinical condition on admis-
sion was classified according to the World Federation of
Neurological Surgeons scale [10]. Delayed cerebral
ischemia (DCI) was defined as a decrease in level of
consciousness of ≥ 2p o i n t so nt h eG l a s g o wC o m a
Scale, the appearance of a focal neurologic deficit, or
both, for ≥ 3 hours, after exclusion of rebleeding, hydro-
cephalus, infection, or metabolic causes for the dete-
rioration [11]. Neurologic outcome was assessed with
the modified Rankin scale at 3 months after the SAH by
a research nurse not involved in patient management
[12].
Treatment
Patients were treated according to a standard SAH pro-
tocol. The goal of fluid therapy was to maintain normo-
volemia. The guidance of fluid therapy depended on
treatment allocation for the parent Optica study. In the
control group, fluid administration was adjusted on the
basis of the fluid balance, calculated every 6 hours, by
subtracting urinary volume f r o mt o t a lo r a la n di n t r a v e -
nous intake. The aim was to keep the daily fluid balance
at 750 ml positive, to compensate for insensible fluid
loss. In the intervention group, fluid management was
adjusted on the basis of daily blood-volume measure-
ments, in an effort to keep blood volume inside the nor-
movolemic range. Central venous pressure was not
routinely monitored in patients with good or reasonable
neurologic condition (WFNS grades I and II). Oral
nimodipine, 60 mg every 4 hours, was started in all
patients. If signs of delayed cerebral ischemia developed,
fluid management was continued according to treatment
allocation; no intentional hypervolemia or hemodilution
was used, but induced hypertension could be applied.
Treating physicians could overrule the protocol-based
fluid therapy in both study groups if they considered
this vital to the patient’s interest.
Outcomes
A diagnosis of PED was made by the treating physicians
and the consulting radiologists, based on clinical signs
(dyspnea, tachypnea, basal pulmonary crackles, presence
of frothy sputum, hypoxemia) in combination with char-
acteristic bilateral pulmonary infiltrates on the chest
radiograph [4]. Presence of pneumonia excluded a diag-
nosis of PED.
Blood volume and cardiac output were measured daily
in all included patients by means of pulse dye densito-
metry (PDD; Nihon Kohden Corporation, Tokyo, Japan).
This dye-dilution technique uses pulse spectrophotome-
try, as developed for pulse oximetry, for measurement of
the concentration of an injected dye (indocyanine green;
SERB Laboratoires Pharmaceutiques, Paris, France).
PDD was previously validated, showing good accuracy in
measured blood volume, and was used before in patients
after SAH [7,13]. A measured blood volume of 60 to
80 ml/kg was classified as normal, as was a cardiac
index of 2.5 to 4 L/min/m
2 [14].
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We calculated individual per-patient mean-blood-
volume values for all patients developing pulmonary
edema, taken into consideration only the blood-volume
measurements from the first day after SAH through the
day on which pulmonary edema was diagnosed for the
first time in that patient. We calculated the median
number of days after SAH after which pulmonary
edema was diagnosed. We then assessed the per-patient
mean-blood-volume values for patients in whom pul-
monary edema did not develop, based on the measure-
ments made until this median number of days after
SAH. To compare mean values between patients with
and without pulmonary edema, we took into account
that, in each patient, multiple blood-volume measure-
ments were performed during the study period. There-
fore we used weighted linear regression for comparison
of per-patient mean values, in which the inverse of the
standard error of the per-patient mean was taken as
weight.
Advanced age, obesity, and a poor clinical grade on
admission have all been associated with a decrease in
blood volume. As we aimed to analyze the relation
between PED and volume status, we decided to adjust
for these variables (age, weight, WFNS-grade). A similar
analysis was used for comparison of cardiac index and
fluid balance in all patients, to compare measurements
of patients with pulmonary edema between intervention
and control groups of the Optica study, and to compare
measurements in patients in whom PED developed on
the first day after SAH or on later days. Results are pre-
sented as mean differences with corresponding 95% con-
fidence intervals.
We compared the proportion of patients with pul-
monary edema between the intervention and control
groups in terms of risk ratio (RR), with 95% confidence
intervals. The same analysis was used to compare the
use of diuretics in patients in whom PED did or did not
develop in the following days.
Results
Patient enrollment
Between January 2006 and June 2007, 182 patients
with aneurysmal SAH were admitted to the UMC
Utrecht. Of these, 104 patients were included, two of
whom died of rebleeding before the first blood volume
measurement (Figure 1). Baseline characteristics of
patients with or without PED are listed in Table 1.
Patients in PED developed were older and more often
were admitted in a poor clinical condition. No differ-
ence was found in baseline characteristics between
patients from the intervention and the control groups.
Outcome measurements
Neurogenic pulmonary edema was diagnosed after a
mean of 4.4 days (95% CI, 3.0 to 5.9) after SAH. Calcu-
lated differences in blood volume, cardiac index, and
fluid balance between patients with and without PED
are presented in Table 2. The mean blood volume of
patients with PED was in the hypovolemic range,
whereas the mean blood volume of patients without
PED was in the normal range. After adjusting for age,
weight, and WFNS grade, blood volumes remained
lower in patients with PED, whereas cardiac index and
fluid balance did not differ statistically significantly
between patients with or without PED. No difference
was noted in mean CBV between patients with PED
diagnosed early and late.
PED was diagnosed in 17 (17%) of the 102 evaluated
patients. It occurred in 12 (22%) of the 54 patients in
the intervention group and in five (10%) of the 48
patients in the control group (RR, 2.1; 95% CI, 0.8 to
5.6). A comparison in determinants between both
groups is provided in Table 3. The mean blood volume
of the patients with PED in the intervention group was
slightly higher than that in the control group, but still in
the hypovolemic range. Diuretics were used in seven
(8%) of 85 patients without PED and in 11 (65%) of 17
patients with PED, in the days before PED was diag-
nosed (RR, 7.9; 95% CI, 3.6 to 17.3).
Discussion
Our results show that PED after SAH is accompanied by
a strong decrease in blood volume. Patients with PED
had a mean blood volume in the hypovolemic range in
the days preceding the diagnosis of PED. Patients in
whom PED developed more often had diuretics pre-
scribed by the treating physicians in the days before the
diagnosis of PED was made. Cardiac index tended to be
somewhat lower and fluid balance somewhat more posi-
tive in patients with PED, but these differences were no
longer statistically significant after adjusting for age,
weight, and clinical condition. Calculations were based
on measurements obtained in the time period from the
day after SAH until the day PED was diagnosed, so
these results were not influenced by any therapeutic
measures initiated by the treating physicians to counter-
act PED.
We were unable to find any previous studies in which
blood volume was actually measured in PED patients,
either in patients with a cardiac origin of the edema (by
systolic or diastolic pump failure), or in patients with
noncardiogenic edema (by increased pulmonary capillary
permeability). Central venous pressure and pulmonary
capillary occlusion pressure are often used in PED to
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relation exists between these pressures and the presence
of neurogenic PED, or between these pressures and
measured blood volume [5,16,17].
It was previously noticed that neurogenic PED devel-
ops earlier in patients with a normal systemic circulating
volume, compared with hypovolemic patients [1,18].
Patients in the Optica intervention group more often
had blood volumes in the normovolemic range than did
control group patients [9]. The present analysis showed
that intervention-group patients tended to be at
increased risk of PED and that patients in the interven-
tion group developing PED tended to have a more posi-
tive fluid balance and a higher (but still reduced) mean
blood volume. Interpretation of these differences must
be made with caution because of the small number of
Assessed for eligibility: 
Patients admitted to UMC 
Utrecht after aneurysmal SAH 
(n = 182) 
Exclusion: 
Admitted > 72 hours
(n = 31) 
Declined to participate 
(n = 25) 
Imminent death
(n = 17) 
Liver failure
(n = 2)
To other hospital 
(n = 2)
Possible ICG allergy 
(n = 1)
Allocated to control group
(n = 48) 
Received allocated treatment 
(n = 48) 
Analyzed patients
(n = 48) 
Developed pulmonary edema
(n = 5) 
Allocation for Optica
Analysis
Completion
Enrollment
Inclusion  
(n = 104)
Allocated to intervention group
(n = 56) 
Received allocated treatment
(n = 54) 
Did not receive allocated treatment: 
Died from rebleeding before first 
blood volume measurement 
(n = 2) 
Completed study period
(n = 46) 
Did not complete study period: 
Died during study 
(n = 7) 
Venous access too difficult
(n = 1)
Completed study period
(n = 42) 
Did not complete study period:
Died during study 
(n = 4) 
Transferred to other hospital
(n = 1)
Consent withdrawn 
(n = 1)
Analyzed patients 
(n = 54) 
Developed pulmonary edema
(n = 12) 
Figure 1 Flow chart of patient inclusion and treatment allocation.
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cate that measures to prevent hypovolemia after SAH
lead to an increased risk of PED.
The cardiac index was slightly (nonsignificantly) lower
in patients with PED than in those without, but not to
such an extent as to indicate cardiac failure. This sug-
gests that PED in our study did not have a cardiogenic
origin, but was likely neurogenic or part of a systematic
inflammatory response syndrome (SIRS). The reduced
blood volume we found in patients with PED also sug-
gests a noncardiogenic cause. A reduction in cardiac
index could be explained by the cardiac dysfunction
often accompanying neurogenic PED. Alternatively, pre-
existing hypovolemia may have led to a decrease in car-
diac filling and thereby to a reduction in cardiac index.
Because we did not perform serial echocardiography, we
were unable to make this distinction.
The reduction in blood volume we observed in
patients with PED after SAH does not necessary imply a
causal relation. Patients in whom PED developed were
older and more often admitted in a poor clinical condi-
tion, which is in agreement with previous studies [4]. Ill
patients tend to develop more signs of SIRS, with capil-
lary leakage and the formation of a generalized edema
[19]. This loss of fluid from the circulation reduces
blood volume. Fluid retention is the usual reaction of
the body to a reduction in volume status, thereby lead-
ing to a more-positive fluid balance. Both the presence
o fg e n e r a l i z e de d e m aa n dap o sitive fluid balance could
erroneously be interpreted as a sign of fluid overload in
a patient with SIRS. This could trigger the treating phy-
sicians to deviate from the fluid-management protocol
and to use diuretics. A previous study found no associa-
tion between the fluid balance and actual measured
blood volume [20]. In our present study, diuretics were
used far more often in patients in whom, in later days,
PED developed than in patients without edema. We did
not collect information on the motives for the use of
diuretics. However, the use of diuretics in patients with
Table 1 Patient characteristics
Pulmonary
edema
No pulmonary
edema
Number of patients 17 85
Women 14 (82%) 64 (75%)
Age (years, mean ± SD) 66 ± 14 55 ± 14
Length (cm, mean ± SD) 170 ± 8 171 ± 10
Weight (kg, mean ± SD) 79 ± 13 75 ± 17
Aneurysm location
Anterior cerebral
artery
7 (41%) 38 (45%)
Carotid artery 6 (35%) 20 (24%)
Middle cerebral artery 2 (12%) 15 (18%)
Posterior circulation 2 (12%) 12 (14%)
WFNS grade on admission
I 5 (29%) 42 (49%)
II 5 (29%) 13 (15%)
III 0 (0) 7 (8%)
IV 4 (24%) 14 (17%)
V 3 (18%) 9 (11%)
Aneurysm treatment
Coiling 10 (59%) 50 (59%)
Clipping 3 (18%) 28 (33%)
Delayed cerebral ischemia 9 (53%) 27 (32%)
Modified Rankin Scale at
3 months
1 3 (18%) 30 (35%)
2 4 (24%) 19 (22%)
3 3 (18%) 9 (11%)
4 2 (12%) 3 (4%)
5 2 (12%) 5 (6%)
Dead 3 (18%) 16 (19%)
Data are expressed as numbers with percentages or means with standard
deviations.
SD, standard deviation; WFNS, World Federation of Neurological Surgeons.
Table 2 Calculated differences in outcome measurements
Pulmonary edema
Diagnosed n = 17 Not diagnosed n = 85 Mean difference Adjusted mean difference
Blood volume 56.6 66.8 -11.3 -8.0
(52.3 to 60.8) (64.1 to 69.4) (-16.5 to -6.1) (-14.0 to -2.0)
Cardiac index 2.6 3.2 -0.5 -0.3
(2.2 to 2.9) (3.1 to 3.4) (-0.9 to -0.1) (-0.7 to 0.1)
Fluid balance +1.6 +1.1 +0.2 +0.1
(1.0 to 2.2) (0.9 to 1.3) (-0.2 to 0.7) (-0.4 to 0.6)
Presented are mean values with 95% confidence interval of blood volume (ml/kg), cardiac index (L/min/m
2), and fluid balance (L/day). Differences between
patients with or without pulmonary edema are adjusted for age, weight, and WFNS grade on admission.
n = numbers of patients.
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i m p o r t a n tr o l ei nt h er e d u c t i o ni ni n t r a v a s c u l a rv o l u m e
that we observed.
Furthermore, any formation of PED implies a fluid
shift from the vascular system to the lung tissue. There-
fore, the occurrence of PED could contribute to a
further reduction in blood volume.
A limitation of our study is that the diagnosis of PED
was based on clinical criteria in combination with chest
radiograph findings. The physicians responsible for
patient care were not blinded for treatment allocation.
This may have contributed to an increase of PED diag-
nosed in the intervention group, because some clinicians
believed that patients in the intervention group were at
increased risk for hypervolemia and pulmonary edema.
We did not categorize the severity of edema. Less-severe
instances of pulmonary edema may have escaped detec-
tion, as extravascular lung water must increase by >30%
for edema to be visible on a chest radiograph [15]. We
did not routinely monitor central venous pressure or
pulmonary capillary wedge pressure in these patients,
because of the poor relation between these pressures
and actual volume status. Another limitation concerns
the definition of normal blood volume. Previous studies
found “normal” blood volume values in adults of ~70
ml/kg [7,14]. However, the changes in blood volume
that occur as a result of illness or therapy are incomple-
tely understood [21]. For this reason, we used wide mar-
gins in our definition of normovolemia (60-80 ml/kg).
Even with these large margins, patients developing PED
fell outside this range and were considered hypovolemic.
Notably, volume status is only one of the factors
determining the adequacy of tissue perfusion. To evalu-
ate the patient’s cardiovascular status, many hemody-
namic parameters must be taken into consideration
together and seen in the context of the overall clinical
condition.
Conclusions
Patients with PED after SAH must be considered hypovo-
lemic and therefore at increased risk of delayed cerebral
ischemia. This renders fluid management in these
patients especially difficult. Measures aimed at relieving
pulmonary congestion and improving oxygenation (for
example, preload reduction) might increase hypovolemia,
whereas measures to improve volume status might wor-
sen pulmonary edema and possible hypoxemia. Both
hypovolemia and hypoxemia are extremely deleterious
for the recently injured brain. To balance these poten-
tially conflicting goals, clinicians might consider refrain-
ing from measures that reduce preload and instead use
early (noninvasive) positive-pressure ventilation to main-
tain oxygenation. This might allow administration of
additional fluid to maintain normovolemia without a
further decrease in arterial oxygen saturation. The effects
of such a treatment policy on circulation, ventilation, and
neurologic outcome must be formally studied.
Key messages
￿ Patients with pulmonary edema after aneurysmal
SAH have a decrease in circulating blood volume.
￿ T h e s ep a t i e n t sm u s tb ec o n sidered at high risk of
delayed cerebral ischemia.
￿ Treatment policies for pulmonary edema after SAH
must be balanced against the risk of further increasing
hypovolemia.
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